Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Blank Check IPOs (SPACS) -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (1739)	12/19/2008 8:21:03 AM
From: Glenn Petersen	Read Replies (1) \| Respond to of 3862

Apex Bioventures Acquisition (stock symbol: [t]PEX[/t]), which raised $69 million when it went public in June 2007, has announced that it has signed a letter of intent to acquire an unidentified company. It has until June 13, 2009 to complete the transaction. Apex Bioventures Acquisition Corporation Signs Letter of Intent for Business Combination Monday December 15, 10:58 am ET HILLSBOROUGH, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (Amex: PEX - News) announced today that, on December 13, 2008, it entered into a letter of intent with a company for a business combination. The parties to the letter of intent are currently conducting due diligence and anticipate signing a definitive agreement within the next 45 days. Apex will make an additional announcement in the event it enters into such a definitive agreement. Pursuant to the provisions of Apex's Second Amended and Restated Certificate of Incorporation, Apex now has until June 13, 2009 to complete a business combination. If Apex is unable to complete a business combination by June 13, 2009, it will then liquidate. <snip> biz.yahoo.com